Definitive Healthcare Corp

For the period ended Mar 31, 2025. Filed May 8, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 8, 2025

DH$1.19+6.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 1. Condensed Consolidated Balance Sheets (Unaudited)

CONDENSED CONSOLID ATED BALANCE SHEETS

(in thousands, except number of shares and par value)

	March 31, 2025	December 31, 2024
Assets
Current assets:
Cash and cash equivalents	$106,099	$105,378
Short-term investments	94,574	184,786
Accounts receivable, net	42,923	53,232
Prepaid expenses and other assets	16,173	13,040
Deferred contract costs	13,673	13,736
Total current assets	273,442	370,172
Property and equipment, net	9,483	3,791
Operating lease right-of-use assets, net	6,982	7,521
Other assets	2,991	2,300
Deferred contract costs	14,299	14,389
Intangible assets, net	284,708	297,933
Goodwill	216,752	393,283
Total assets	$808,657	$1,089,389
Liabilities and Equity
Current liabilities:
Accounts payable	$8,218	$10,763
Accrued expenses and other liabilities	26,963	40,896
Deferred revenue	109,724	93,344
Term loan	8,750	13,750
Operating lease liabilities	2,422	2,408
Total current liabilities	156,077	161,161
Long term liabilities:
Deferred revenue	2,790	32
Term loan	162,385	229,368
Operating lease liabilities	7,051	7,586
Tax receivable agreements liability	23,124	49,511
Deferred tax liabilities	13,912	25,088
Other liabilities	7,413	9,449
Total liabilities	372,752	482,195
Equity:
Class A Common Stock, par value $0.001, 600,000,000 shares authorized, 109,646,157 and 113,953,554 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively	110	114
Class B Common Stock, par value $0.00001, 65,000,000 shares authorized, 38,997,184 and 38,995,217 shares issued and outstanding, respectively, at March 31, 2025, and 39,439,198 and 39,375,806 shares issued and outstanding, respectively, at December 31, 2024	—	—
Additional paid-in capital	1,071,732	1,085,445
Accumulated other comprehensive deficit	(1,264)	(610)
Accumulated deficit	(747,802)	(640,574)
Noncontrolling interests	113,129	162,819
Total equity	435,905	607,194
Total liabilities and equity	$808,657	$1,089,389

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.